See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.
Temozolomide and radiation therapy with or without bevacizumab in treating patients with newly diagnosed glioblastoma
eagle-i ID
http://hawaii.eagle-i.net/i/00000130-ddd3-1595-9953-50a980000000
Resource Type
Properties
-
-
ClinicalTrials.gov url
-
http://www.clinicaltrials.gov/ct2/show/NCT00884741?term=RTOG-0825&rank=1
-
-
Intervention
-
Temozolide
-
-
Intervention
-
Radiation therapy
-
-
Intervention
-
Bevacizumab
-
-
Resource Description
-
This randomized phase III trial is studying temozolomide and radiation therapy to compare how well they work when given together with or without bevacizumab in treating patients with newly diagnosed glioblastoma. (gliosarcoma closed to accrual as of 07-13-10).
-
-
Additional Name
-
Phase III double-blind placebo-controlled trial of conventional concurrent chemoradiation and adjuvant temozolomide plus bevacizumab versus conventional concurrent chemoradiation and adjuvant temozolomide in patients with newly diagnosed glioblastoma
-
-
Contact
-
Berenberg, Jeffrey
-
-
PI
-
Berenberg, Jeffrey
-
-
Topic
-
glioblastoma multiforme
-
-
Funded by
-
Radiation Therapy Oncology Group
-
-
Phase
-
Phase 3 clinical trial
-
-
Performed by
-
Clinical Protocol & Data Management Shared Resource
